IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 96

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: NIOSOMES: REVOLUTIONIZING THE FIELD OF TARGETED DRUG DELIVERY SYSTEM
Authors Name: Dhruv Bhavsar
Download E-Certificate: Download
Author Reg. ID:
IJNRD_207582
Published Paper Id: IJNRD2310290
Published In: Volume 8 Issue 10, October-2023
DOI:
Abstract: The rise of nanotechnology has sparked a surge in interest in nanocarriers as an efficient and safe means of delivering drugs. The challenge of achieving efficient and safe drug delivery has long been a concern in the field of medicine. Drug targeting, a mechanism by which drugs are administered in a manner that allows them to interact with specific tissues at a cellular or subcellular level, has emerged as a solution to this challenge. By utilizing modern techniques such as niosomes, drug targeting can be achieved. The use of nanotechnology, particularly the development of nanocarriers for drug delivery, has garnered significant attention due to the potential for these carriers to act as "magic bullets," selectively targeting affected organs and cells while leaving normal tissues unharmed. In recent decades, the formulation of surfactant vesicles has become an increasingly popular tool for improving drug delivery, capturing the interest of scientists in the field of drug delivery systems. Niosomes are molecular clusters that form through the self-association of non-ionic surfactants in an aqueous phase. These unique structures present an innovative and effective drug delivery system known as the novel drug delivery system (NDDS). One of the key advantages of niosomes is their ability to load both hydrophilic and lipophilic drugs. Niosomes are vesicular nano-carriers that are self-assembled through the hydration of non-ionic surfactants, cholesterol, or other amphiphilic molecules. They serve as a versatile drug delivery system with a wide range of applications, including dermal delivery and brain-targeted delivery. Compared to liposomes, niosomes offer several advantages. They are composed of biodegradable and relatively nontoxic non-ionic surfactants, making them a safer option. Additionally, niosomes are more stable and less expensive, providing a cost-effective alternative. This review aims to provide a comprehensive summary of the current research on niosomes. It offers a detailed overview of the formulation components, different types of niosomes, and the effects of these components on the formation of niosomes. The review also covers the fabrication and purification methods, as well as the physical characterization techniques used for niosomes. Furthermore, the review explores the recent applications of niosomes in the pharmaceutical field, including oral, ocular, topical, pulmonary, parental, and transmucosal drug delivery. It also discusses the potential cosmetic applications of niosomes. Finally, the review addresses the limitations of this drug delivery system and provides insights into the future outlook for niosomes.
Keywords: Niosomes, Compositions, Methods of Preparation, Encapsulation, Surfactants, Vesicles and Applications.
Cite Article: "NIOSOMES: REVOLUTIONIZING THE FIELD OF TARGETED DRUG DELIVERY SYSTEM", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 10, page no.c829-c860, October-2023, Available :http://www.ijnrd.org/papers/IJNRD2310290.pdf
Downloads: 000118751
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2310290
Registration ID: 207582
Published In: Volume 8 Issue 10, October-2023
DOI (Digital Object Identifier):
Page No: c829-c860
Country: GANDHINAGAR, Gujarat, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2310290
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2310290
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD